Metastasis of human colon cancer is altered by modifying expression of the beta-galactoside-binding protein galectin 3.

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Gastroenterology

• Publication date

  1998-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/S0016-5085(98)70195-7PMID 9679034
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• BH 1 ( NWGR ) Domain of Bcl-2 Family Galectin-3 : A Novel Antiapoptotic Molecule with A Functional Updated

  2006cited by this paper
• Endogenous galactoside-binding lectins: a new class of functional tumor cell surface molecules related to metastasis

  2004cited by this paper
• Modifying expression of the β-galactoside binding protein galectin-3 significantly alters the metastatic ability of human colon cancer cells

  1998cited by this paper
• Differential expression of galectin 3 and galectin 1 in colorectal cancer progression.

  1997cited by this paper
• Expression of the endogenous galactose‐binding protein galectin‐3 correlates with the malignant potential of tumors in the central nervous system

  1997cited by this paper
• Galectins: multipurpose carbohydrate-binding proteins implicated in tumor biology.

  1997cited by this paper
• Galectin-3: a novel antiapoptotic molecule with a functional BH1 (NWGR) domain of Bcl-2 family.

  1997cited by this paper
• Enhanced sialylation of mucin-associated carbohydrate structures in human colon cancer metastasis.

  1996cited by this paper
• Colon cancer mucin: A new ligand for the β-galactoside-binding protein galectin-3

  1996cited by this paper
• Colon cancer mucin: a new ligand for the beta-galactoside-binding protein galectin-3.

  1996cited by this paper
• Expression of galectins in head and neck squamous cell carcinoma

  1996cited by this paper
• Possible roles of tumor-associated carbohydrate antigens.

  1996cited by this paper
• Carcinoembryonic antigen and other glycoconjugates act as ligands for galectin-3 in human colon carcinoma cells.

  1995cited by this paper
• Functional evidence that cell surface galectin-3 mediates homotypic cell adhesion.

  1995cited by this paper
• The Laminin α1 Chain Ile-Lys-Val-Ala-Val (IKVAV)-containing Peptide Promotes Liver Colonization by Human Colon Cancer Cells

  1995cited by this paper
• The laminin alpha 1 chain Ile-Lys-Val-Ala-Val (IKVAV)-containing peptide promotes liver colonization by human colon cancer cells.

  1995cited by this paper
• Expression of an endogenous galactose‐binding lectin correlates with neoplastic progression in the colon

  1995cited by this paper
• Differential expression of galectin-1 and galectin-3 in thyroid tumors. Potential diagnostic implications.

  1995cited by this paper
• Induction of tumorigenicity by galectin-3 in a nontumorigenic human breast-carcinoma cell-line.

  1995cited by this paper
• Expression of a 31‐kDa lactoside‐binding lectin in normal human gastric Mucosa and in primary and metastatic gastric carcinomas

  1994cited by this paper
• Galectins. Structure and function of a large family of animal lectins.

  1994cited by this paper
• Galectins: a family of animal beta-galactoside-binding lectins.

  1994cited by this paper
• Structure of the murine Mac-2 gene. Splice variants encode proteins lacking functional signal peptides.

  1993cited by this paper
• Structure-function relationship of a recombinant human galactoside-binding protein.

  1993cited by this paper
• Regulation of the expression of galactoside-binding lectin during human monocytic differentiation.

  1993cited by this paper
• Cloning and characterization of a human Mac-2-binding protein, a new member of the superfamily defined by the macrophage scavenger receptor cysteine-rich domain.

  1993cited by this paper
• Inverse modulation of steady-state messenger RNA levels of two non-integrin laminin-binding proteins in human colon carcinoma.

  1992cited by this paper
• Increased content of an endogenous lactose-binding lectin in human colorectal carcinoma progressed to metastatic stages.

  1991cited by this paper
• Mucin production by human colonic carcinoma cells correlates with their metastatic potential in animal models of colon cancer metastasis.

  1991cited by this paper
• Carbohydrate-binding protein 35 is the major cell-surface laminin-binding protein in colon carcinoma.

  1991cited by this paper
• Molecular cloning and chromosomal mapping of a human galactoside-binding protein.

  1991cited by this paper
• Evidence for the role of 34‐kDa galactoside‐binding lectin in transformation and metastasis

  1990cited by this paper
• Biochemical and immunological comparisons of carbohydrate-binding protein 35 and an IgE-binding protein.

  1989cited by this paper
• Identification of the metastasis-associated, galactoside-binding lectin as a chimeric gene product with homology to an IgE-binding protein.

  1989cited by this paper
• Expression of two different endogenous galactoside-binding lectins sharing sequence homology.

  1988cited by this paper
• A simple salting out procedure for extracting DNA from human nucleated cells.

  1988cited by this paper
• Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure.

  1987cited by this paper
• Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

  1987cited by this paper
• Transformation‐related changes in the expression of endogenous cell lectins

  1987cited by this paper
• Differential expression of endogenous lectins on the surface of nontumorigenic, tumorigenic, and metastatic cells.

  1986cited by this paper
• Mac-2, a novel 32,000 Mr mouse macrophage subpopulation-specific antigen defined by monoclonal antibodies.

  1982cited by this paper

• Automatic target-seeking nanoparticle inhibiting orthotopic drug-resistant colon cancer and liver metastases via regulating cancer cell adhesion and proliferation

  2025cites this paper
• The role of galectin-3 in bone homeostasis: A review.

  2024cites this paper
• The content of soluble forms of galectins -1, -3, -4, -7, -9 in patients with renal cell cancer of various morphological types

  2024cites this paper
• The pleiotropic role of galectin-3 in melanoma progression: Unraveling the enigma.

  2023cites this paper
• Galectin-3 Mediates Tumor Progression in Astrocytoma by Regulating Glycogen Synthase Kinase-3β Activity

  2023cites this paper
• Galectin functions in cancer-associated inflammation and thrombosis

  2023cites this paper
• Aconiti Lateralis Radix Praeparata as Potential Anticancer Herb: Bioactive Compounds and Molecular Mechanisms

  2022cites this paper
• Highlights on the Role of Galectin-3 in Colorectal Cancer and the Preventive/Therapeutic Potential of Food-Derived Inhibitors

  2022cites this paper
• On the origin of metastases: Induction of pro-metastatic states after impending cell death via ER stress, reprogramming, and a cytokine storm.

  2022cites this paper
• Evaluating the Role of Galectins in Clathrin-Independent Endocytosis.

  2022cites this paper
• KIT Mutations Correlate with Higher Galectin Levels and Brain Metastasis in Breast and Non-Small Cell Lung Cancer

  2022cites this paper
• Nutrient-responsive O-GlcNAcylation dynamically modulates the secretion of glycan-binding protein galectin 3

  2022cites this paper
• The expression of Galectin-3 in endometrial cancer: a systematic review of the literature

  2021cites this paper
• Nutrient Responsive O-GlcNAcylation Dynamically Modulates Galectin 3 Secretion

  2021cites this paper
• Multifunctional Core-Shell Glyco-Nanoparticles for Galectin-3 Targeted Trigger responsive Combination Chemotherapy.

  2020cites this paper
• Non-classical role of Galectin-3 in cancer progression: translocation to nucleus by carbohydrate-recognition independent manner

  2020cites this paper
• Immunotherapy and potential molecular targets for the treatment of pituitary adenomas resistant to standard therapy: a critical review of potential therapeutic targets and current developments.

  2020cites this paper
• Glycosylation and glycan interactions can serve as extracellular machinery facilitating clathrin‐independent endocytosis

  2019cites this paper
• Sweetening the hallmarks of cancer: Galectins as multifunctional mediators of tumor progression

  2019cites this paper
• Distinct cargo-specific response landscapes underpin the complex and nuanced role of galectin–glycan interactions in clathrin-independent endocytosis

  2018cites this paper
• Analysis of HCV and HCC: Identifying Biomarkers for Monitoring HCV-Cirrhotic Patients Awaiting Liver Transplantation

  2018cites this paper
• Galectin-3 alters the lateral mobility and clustering of β1-integrin receptors

  2017cites this paper
• METHOD AND KIT FOR PREDICTING CANCER FIELD OF THE INVENTION

  2017cites this paper
• Évaluation du dosage sanguin de la galectine 3 dans le bilan pré opératoire des nodules thyroïdiens

  2017cites this paper
• Galectin-3 in Obesity and Endotoxin-Induced Inflammation

  2016cites this paper
• Caveolin-1 and membrane domain regulation of focal adhesions and tumor cell migration

  2016influential citation
• Antitumor effects of galectin-3 inhibition in human renal carcinoma cells

  2016cites this paper
• Gene silencing of galectin-3 changes the biological behavior of Eca109 human esophageal cancer cells

  2015cites this paper
• 2015 Advances in Colorectal Cancer Role of phytochemicals in colorectal cancer prevention

  2015cites this paper
• The galectin lattice at a glance

  2015cites this paper
• Clinicopathologic Significance of Galectin-3 and Glucose Transporter 1 Expressions in Colorectal rCance

  2015cites this paper
• Galectin-3 as a potential biomarker in colorectal cancer?

  2015cites this paper
• Glycosylation characteristics of colorectal cancer.

  2015cites this paper
• Immunohistochemical Expression of Galectin-3 in Colorectal Carcinoma

  2015cites this paper
• Role of phytochemicals in colorectal cancer prevention.

  2015cites this paper
• Multi Functional Diagnostic Exploitation of Human Galectin-3

  2015cites this paper
• The effects of vincristine sulfate on expression of galectin-3, Bcl-2, and carbohydrate structures specific for EEL, GSL-1, and RCA-1 lectins in bitches with naturally occurring canine transmissible venereal tumor

  2014cites this paper
• Revealing the molecular mechanism of colorectal cancer by establishing LGALS3-related protein-protein interaction network and identifying signaling pathways.

  2014cites this paper
• Targeting prostate carcinoma by G3-C12 peptide conjugated N-(2-hydroxypropyl)methacrylamide copolymers.

  2014cites this paper
• Intracellular galectins in cancer cells: potential new targets for therapy (Review).

  2014cites this paper
• The effects of vincristine sulfate on expression of galectin-3 , Bcl-2 , and carbohydrate structures specific for EEL , GSL-1 , and RCA-1 lectins in bitches with naturally occurring canine transmissible venereal tumor

  2014cites this paper
• Galectin-3 regulation of non small cell lung cancer growth

  2014cites this paper
• Galectin-3 and HBME help the differential diagnosis of thyroid malignancies in Fine Needle Aspiration Cytology

  2013cites this paper
• Overexpression of galectin-3 enhances migration of colon cancer cells related to activation of the K-Ras–Raf–Erk1/2 pathway

  2013cites this paper
• Recent advances toward the development of inhibitors to attenuate tumor metastasis via the interruption of lectin-ligand interactions.

  2013cites this paper
• Study of Galectin 3 and Matrix Metalloproteinase -9 as Prognostic Markers in Colon Cancer

  2013cites this paper
• Investigation of the MUC1-independent action of circulating galectins in metastasis promotion

  2013cites this paper
• Galectin-3C: Human lectin for treatment of cancer

  2012cites this paper
• A combinatorial extracellular matrix platform identifies cell-extracellular matrix interactions that correlate with metastasis

  2012cites this paper
• Galectin-3: Forms, Functions, and Clinical Manifestations

  2012cites this paper
• Modified apple polysaccharide prevents against tumorigenesis in a mouse model of colitis-associated colon cancer: role of galectin-3 and apoptosis in cancer prevention

  2012cites this paper
• Anti-Metastatic Activity of Juniperus chinensis Extract by Galectin-3 Inhibition

  2012cites this paper
• Improving the clinical efficacy of cancer vaccines by targeting immune suppression in human tumors

  2012cites this paper
• Cathepsin B-cleavable doxorubicin prodrugs for targeted cancer therapy

  2012cites this paper
• Galectin 3 in Obesity

  2012cites this paper
• Galectins testing: new promises for the diagnosis and risk stratification of chronic diseases?

  2012cites this paper
• Galectin-3 binding and metastasis.

  2012cites this paper
• Molecular Pathology of Cancer Metastasis: Suggestions for Future Therapy

  2012cites this paper
• Overexpression of Galectin-3 and its clinical significance in ovarian carcinoma

  2011cites this paper
• Changes in the expression and subcellular distribution of galectin-3 in clear cell renal cell carcinoma

  2011cites this paper
• The role of galectins in colorectal cancer progression

  2011cites this paper
• Peptide-directed HPMA copolymer-doxorubicin conjugates as targeted therapeutics for colorectal cancer

  2011cites this paper
• Galectin-3 and the skin.

  2011cites this paper
• Qualitative und quantitative Analyse und Vergleich von Tumorantigenen und HLA Klasse I-Liganden in Primärtumoren und Metastasen des Nierenzellkarzinoms

  2011cites this paper
• Differential expression of galectin-3 in advancing thyroid cancer cells: a clue toward understanding tumour progression and metastasis.

  2010cites this paper
• Circulating galectin-3 in the bloodstream: An emerging promoter of cancer metastasis.

  2010cites this paper
• INTEGRATIVE APPROACHES TO Prostate Cancer Treatment

  2010cites this paper
• Galectin-Expression an urologischen Tumoren

  2010cites this paper
• Serum levels of galectin-3 and its ligand 90k/mac-2bp in colorectal cancer patients.

  2010cites this paper
• Diagnostic utility of galectin-3 in thyroid cancer.

  2010cites this paper
• [Galectin expression in urological cancer. Diagnostic, prognostic and therapeutic potential].

  2010cites this paper
• Identification and consequences of galectin-3 expression in pituitary tumors.

  2010cites this paper
• Carbohydrate-based Biomedical Copolymers for Targeted Delivery of Anticancer Drugs

  2010cites this paper
• A Novel Clinically Relevant Animal Model for Studying Galectin-3 and Its Ligands During Colon Carcinogenesis

  2010cites this paper
• Loss of Galectin-3 Expression in Mucinous Colorectal Carcinomas is Associated With 5′CpG Island Methylation in Tunisian Patients

  2010cites this paper
• Tumorigenesis and Neoplastic Progression Expression Profiling of Galectin-3-Depleted Melanoma Cells Reveals Its Major Role in Melanoma Cell Plasticity and Vasculogenic Mimicry

  2010cites this paper
• Glycosylation and Disease

  2010cites this paper
• Implication of the Galectin-3 in colorectal cancer development (about 325 Tunisian patients).

  2010cites this paper
• Galectin-3 mediates nuclear beta-catenin accumulation and Wnt signaling in human colon cancer cells by regulation of glycogen synthase kinase-3beta activity.

  2009cites this paper
• MUC 1 Localization on Cancer Cell Surface Circulating Galectin-3 Promotes Metastasis by Modifying

  2009cites this paper
• Catalytic synthesis of novel 4-C-glycosyl coumarins using a domino Heck reaction/lactonization process

  2009cites this paper
• Serum levels of galectin-3 and its ligand 90k/mac-2bp in colorectal cancer patients

  2009cites this paper
• Proteomic Analysis of HCV Cirrhosis and HCV-Induced HCC: Identifying Biomarkers for Monitoring HCV-Cirrhotic Patients Awaiting Liver Transplantation

  2009cites this paper
• Genetic assessment of the importance of galectin-3 in cancer initiation, progression, and dissemination in mice.

  2009cites this paper
• Inhibitory effect of modified citrus pectin on liver metastases in a mouse colon cancer model.

  2008cites this paper
• Sialylation of β1 Integrins Blocks Cell Adhesion to Galectin-3 and Protects Cells against Galectin-3-induced Apoptosis*

  2008cites this paper
• Expression profiling of Galectin-3-depleted melanoma cells reveals its major role in melanoma cell plasticity and vasculogenic mimicry.

  2008cites this paper
• Expression of galectin-3 correlates with apoptosis in pituitary adenoma cells

  2008cites this paper
• Synthesis of stable and selective inhibitors of human galectins-1 and -3.

  2008cites this paper
• Regulation of galectin‐3 function in mucosal fibroblasts: potential role in mucosal inflammation

  2008cites this paper
• Identification of Galectin-3 and Mucin-Type O-Glycans in Breast Cancer and Its Metastasis to Brain

  2008cites this paper
• Galectin-3 Expression is Ubiquitous in Tumors of the Sellar Region, Nervous System, and Mimics: An Immunohistochemical and RT-PCR Study

  2008cites this paper
• A galectina-3 na fisiologia e no câncer de tiróide: identificação de SNPs no gene LGALS3 e estudo funcional de galectina-3 in vitro e in vivo

  2008cites this paper
• Targeted disruption of the galectin-3 gene results in decreased susceptibility to NNK-induced lung tumorigenesis: an oligonucleotide microarray study

  2008cites this paper
• The galectin family and digestive disease

  2008cites this paper
• Tumorigenesis and Neoplastic Progression Orthotopic Microinjection of Human Colon Cancer Cells in Nude Mice Induces Tumor Foci in All Clinically Relevant Metastatic Sites

  2007cites this paper
• Gene expression profiles of endothelial progenitor cells by oligonucleotide microarray analysis

  2007cites this paper
• Galectins - potential targets for cancer therapy.

  2007cites this paper
• Galectin-3 expression in colorectal cancer: relation to invasion and metastasis.

  2007cites this paper
• Galectin-3 as a marker distinguishing functioning from silent corticotroph adenomas.

  2007cites this paper